These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20620687)

  • 1. [Chronic obstructive pulmonary disease and bronchiectasias].
    García MA; Cataluña JJ
    Arch Bronconeumol; 2010; 46 Suppl 3():11-7. PubMed ID: 20620687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease and bronchiectasis.
    Novosad SA; Barker AF
    Curr Opin Pulm Med; 2013 Mar; 19(2):133-9. PubMed ID: 23287285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudomonas aeruginosa in chronic obstructive pulmonary disease].
    Wavre-Oberhänsli A; Nicod LP
    Rev Med Suisse; 2010 Nov; 6(272):2240-3. PubMed ID: 21207736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease.
    Murphy TF
    Curr Opin Pulm Med; 2009 Mar; 15(2):138-42. PubMed ID: 19532029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.
    Valderrey AD; Pozuelo MJ; Jiménez PA; Maciá MD; Oliver A; Rotger R
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):20-7. PubMed ID: 20727465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
    Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
    Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic bronchial infection: the problem of Pseudomonas aeruginosa].
    Cantón R; Fernández Olmos A; de la Pedrosa EG; del Campo R; Antonia Meseguer M
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():8-13. PubMed ID: 21703473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does coexistence with bronchiectasis influence intensive care unit outcome in patients with chronic obstructive pulmonary disease?
    Gursel G
    Heart Lung; 2006; 35(1):58-65. PubMed ID: 16426936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
    Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-tuberculous mycobacterial infection in patients with non-cystic fibrosis bronchiectasias].
    Martínez-Cerón E; Prados C; Gómez-Carrera L; Cabanillas JJ; López-López G; Álvarez-Sala R
    Rev Clin Esp; 2012 Mar; 212(3):127-30. PubMed ID: 22119262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infectious comorbidity in COPD].
    Jorge RZ; Bonilla AG
    Arch Bronconeumol; 2009; 45 Suppl 4():59-64. PubMed ID: 20116753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
    Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
    Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.
    Gallego M; Pomares X; Espasa M; Castañer E; Solé M; Suárez D; Monsó E; Montón C
    BMC Pulm Med; 2014 Jun; 14():103. PubMed ID: 24964956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic obstructive pulmonary disease and cardiovascular disease].
    Alonso JL
    Arch Bronconeumol; 2010; 46 Suppl 3():18-22. PubMed ID: 20620688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease.
    Martínez-Solano L; Macia MD; Fajardo A; Oliver A; Martinez JL
    Clin Infect Dis; 2008 Dec; 47(12):1526-33. PubMed ID: 18990062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prediction model for bacterial etiology in acute exacerbations of COPD.
    Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
    Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.
    Roche N; Kouassi B; Rabbat A; Mounedji A; Lorut C; Huchon G
    Respiration; 2007; 74(1):19-25. PubMed ID: 16675894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction in COPD experiment (ICE): a hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease.
    van Dijk WD; Heijdra Y; Scheepers PT; Lenders JW; van Weel C; Schermer TR
    Med Hypotheses; 2010 Feb; 74(2):277-80. PubMed ID: 19800175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease in patients who have HIV infection.
    Crothers K
    Clin Chest Med; 2007 Sep; 28(3):575-87, vi. PubMed ID: 17720045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.